Bictegravir 1611493-60-7
Sharaxaada
Bictegravir waa sheeko cusub, horjooge awood leh oo HIV-1 ah oo lagu daro IC50 ee 7.5 nM.
In Vitro
Bictegravir (BIC) waxay joojisaa dhaqdhaqaaqa wareejinta xadhigga IC50 ee 7.5± 0.3 nMMarka loo eego joojinta dhaqdhaqaaqa wareejinta xargaha, Bictegravir waa ka hortag aad u daciif ah oo ah 3"Waxqabadka HIV-1 IN, oo leh IC50 ee 241±51 nM.Bictegravir waxay kor u qaadaysaa ururinta 2-LTR wareegyada ~ 5-laab marka loo eego kantaroolka la daweeyay ee jeesjeeska ah waxayna yaraynaysaa qadarka alaabta isdhexgalka dhabta ah ee unugyada cudurka qaba 100-laab.Bictegravir waxay si xoog leh u joojisaa ku-noqoshada HIV-1 ee labadaba unugyada MT-2 iyo MT-4 ee leh EC50s ee 1.5 iyo 2.4 nM, siday u kala horreeyaan.Bictegravir waxay soo bandhigtaa saameyn xoog leh oo fayruska ka-hortagga ah labadaba CD4+ T lymphocytes aasaasiga ah iyo monocyte-derived macrophages, oo leh EC50s ee 1.5±0.3 nM iyo 6.6±4.1 nM, siday u kala horreeyaan, kuwaas oo u dhigma qiyamka laga helay xariiqyada T-cell[1].
MCE si madaxbanaan uma xaqiijin saxnaanta hababkan.Waxay yihiin tixraac kaliya.
| Lambarka NCT | Kafiil | Xaalad | Taariikhda billowga | Marxaladda |
| NCT03998176 | Jaamacadda Nebraska | Sayniska Gilead | HIV-1-cudurka | Oktoobar 9, 2019 | Wajiga 4 |
| NCT03789968 | Thomas Jefferson University|Jaamacadda Maryland, College Park|Indiana University Health|Xarunta Isbitaalka Brooklyn|Jaamacadda Illinois ee Chicago | HIV+AIDS | Sebtember 1, 2019 | |
| NCT04249037 | Jaamacadda Colorado, Denver | Sayniska Gilead | HIV+AIDS | Maarso 1, 2020 | Ma khuseyso |
| NCT04132674 | Xarunta cudurada faafa ee Vancouver | Fayraska Immundeficiency Immunodeficiency Infection | Isticmaalka Daroogada | November 26, 2018 | Wajiga 4 |
| NCT04054089 | Cristina Mussini | Jaamacadda Modena iyo Reggio Emilia | Caabuqa HIV | Sebtembar 2019 | Wajiga 4 |
| NCT04155554 | Azienda Ospedaliera Universitaria Senese|Jaamacadda Katooliga ee Qalbiga Xurmada leh|Ospedale Policlinico San Martino|Azienda Ospedaliera San Paolo|Ospedale Amedeo di Savoia | HIV-1-cudurka | Janaayo 29, 2020 | Wajiga 3 |
| NCT02275065 | Sayniska Gilecaad | Caabuqa HIV-1 | Oktoobar 2014 | Wajiga 1 |
| NCT03711253 | Jaamacadda Koonfurta California | Caabuqa HIV Ba'an | Oktoobar 14, 2019 | Wajiga 4 |
| NCT02400307 | Sayniska Gilecaad | HIV | Abriil 17, 2015 | Wajiga 1 |
| NCT03499483 | Caafimaadka Bulshada Fenway | Kahortagga HIV | Janaayo 24, 2019 | Wajiga 4 |
| NCT03502005 | Kooxda Cilmi-baarista Midland, Inc.| Sayniska Gilead | Fayraska difaaca jirka aadanaha | Maarso 1, 2018 | Wajiga 4 |
Qaab dhismeedka kiimikada
Soo jeedin18Mashaariicda Qiimaynta Joogtada Tayada ee la ansixiyay4iyo6mashaariicda ayaa ku socda ansixinta.
Nidaamka maaraynta tayada sare ee caalamiga ah ayaa dhigay aasaas adag oo iib ah.
Kormeerka tayada wuxuu ku socdaa dhammaan wareegga nolosha ee alaabta si loo hubiyo tayada iyo saameynta daaweynta.
Kooxda Arrimaha Sharciyaynta Xirfadlayaasha waxay taageertaa shuruudaha tayada inta lagu jiro codsiga iyo diiwaangelinta.
Khadka Baakadaha ee Countec ee Kuuriya
Khadka baakadaha dhalada ee Taiwan CVC
Taliyaaniga CAM Khadka Baakadaha
Jarmal Fette Machine Compacting
Japan Viswill Tablet Detector
Qolka Xakamaynta DCS
